Literature DB >> 9915317

Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness?

H G Wakeling1, J B Zimmerman, S Howell, P S Glass.   

Abstract

BACKGROUND: An effect compartment has been postulated, and the ke0 has been quantified for several intravenous anesthetic drugs using electroencephalography (EEG) as the measure of effect. The authors wanted to validate that loss of responsiveness (LOR) was related to targeting an effect compartment concentration rather than a central compartment (plasma) concentration.
METHODS: Twenty American Society of Anesthesiologists physical status I and II patients were randomized to receive propofol administered to a target central compartment or target effect compartment site concentration of 5.4 microg/ml propofol administered by a target-controlled infusion (TCI) using a previously validated set of pharmacokinetic parameters and a ke0 of 0.63 min(-1). Every 30 s for the first 5 min and every minute for the second 5 min the patients were asked to open their eyes. The time to LOR was measured by a blinded investigator. The authors also simulated the time to reach the desired target effect site concentration using varying ke0 values.
RESULTS: The median time to LOR in the group targeted to a predicted plasma propofol concentration was 3.02 min and 1.23 min in the group targeted to a predicted effect compartment propofol concentration (P < 0.05). LOR to command in both groups occurred at a predicted median effect compartment concentration of 4.55 microg/ml. Simulations demonstrated that the time predicted to LOR targeting an effect site concentration of 5.4 microg/ml is markedly altered by the value chosen for the ke0.
CONCLUSIONS: This study confirms the utility of the ke0 value to describe the effect compartment for propofol. The authors also illustrate the importance of selecting the correct ke0 value for the pharmacokinetic parameters used within the TCI system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915317     DOI: 10.1097/00000542-199901000-00014

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  15 in total

Review 1.  [Modern concepts in pharmacokinetics of intravenous anesthetics].

Authors:  T Heidegger; C F Minto; T W Schnider
Journal:  Anaesthesist       Date:  2004-01       Impact factor: 1.041

2.  Effect-compartment equilibrium rate constant (keo) for propofol during induction of anesthesia with a target-controlled infusion device.

Authors:  Thiam Aun Lim; Wai Hong Wong; Kin Yuee Lim
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

3.  Comparison of the qCON and qNOX indices for the assessment of unconsciousness level and noxious stimulation response during surgery.

Authors:  Umberto Melia; Eva Gabarron; Mercé Agustí; Nuria Souto; Patricia Pineda; Joan Fontanet; Montserrat Vallverdu; Erik Weber Jensen; Pedro Gambus
Journal:  J Clin Monit Comput       Date:  2016-10-20       Impact factor: 2.502

4.  Race-Specific Pharmacodynamic Model of Propofol-Induced Loss of Consciousness.

Authors:  Samsun Lampotang; David E Lizdas; Hartmut Derendorf; Nikolaus Gravenstein; Benjamin Lok; John P Quarles
Journal:  J Clin Pharmacol       Date:  2016-03-28       Impact factor: 3.126

Review 5.  Induction of anaesthesia: a guide to drug choice.

Authors:  Nathalie Nathan; Isabelle Odin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Titration of the plasma effect site equilibrium rate constant of propofol; a link method of 'Concentration-Probability-Time'.

Authors:  Jong-Yeop Kim; Sung-Yong Park; Sun-Kyung Park; Jin-Soo Kim; Sang-Kee Min
Journal:  Korean J Anesthesiol       Date:  2010-03-29

7.  Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening.

Authors:  Hiroko Iwakiri; Noboru Nishihara; Osamu Nagata; Takashi Matsukawa; Makoto Ozaki; Daniel I Sessler
Journal:  Anesth Analg       Date:  2005-01       Impact factor: 6.627

8.  The peak bispectral index time cannot predict early phase propofol pharmacodynamics with effect site-controlled infusion algorithm.

Authors:  Jing Niu; Shan-Juan Wang; Ma-Zhong Zhang; Yong-Lei Huang; Lin Song; Qing Yu; Wen-Yin Xu
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

9.  The influence of the severity of chronic virus-related liver disease on propofol requirements during propofol-remifentanil anesthesia.

Authors:  Jian Wu; Su-Qin Huang; Qing-Lian Chen; Shu-Sen Zheng
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

10.  The potential regimen of target-controlled infusion of propofol in flexible bronchoscopy sedation: a randomized controlled trial.

Authors:  Ting-Yu Lin; Yu-Lun Lo; Chung-Hsing Hsieh; Yung-Lun Ni; Tsai-Yu Wang; Horng-Chyuan Lin; Chun-Hua Wang; Chih-Teng Yu; Han-Pin Kuo
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.